Robuta

Sponsor of the Day: Jerkmate
https://www.biopharmadive.com/press-release/20260321-samsung-biologics-labor-union-warns-of-structural-supply-chain-risk-amid/ Samsung Biologics Labor Union Warns of "Structural Supply Chain Risk" Amid Labor Dispute,... supply chain risksamsung biologicslabor unionamid disputewarns https://samsungbiologics.com/careers/working-with-us/diversity-inclusion Diversity & Inclusion | Samsung Biologics More than 100 Global Experts from 11 different countries are employed at Samsung Biologics, and we have been recognized as a “Best Family-Friendly Management”... diversity inclusionsamsung biologics https://www.koreatimes.co.kr:443/business/companies/20260424/court-ruling-undermines-samsung-biologics-labor-unions-strike-plans Court ruling undermines Samsung Biologics labor union's strike plans - The Korea Times Apr 24, 2026 - A court ruling has partly curbed Samsung Biologics labor union’s plan to stage an all-out strike, in a move seen as undermining its momentum. The I... court rulingsamsung biologicslabor unionkorea timesundermines https://samsungbiologics.com/about/milestones Milestones | Samsung Biologics As a leading end-to-end service provider, Samsung Biologics has achieved a great number of milestones over the past decade. samsung biologicsmilestones https://samsungbiologics.com/careers/recruitment-support/step1 Jobs | Samsung Biologics Complete your profile to find a role that matches your interest. samsung biologicsjobs https://samsungbiologics.com/services/biologics-overview Samsung Biologics | Global CDMO for End-to-End Biopharma Services Samsung Biologics is a leading global CDMO providing end-to-end biologics development, CGMP manufacturing, and aseptic fill/finish services for biopharma... samsung biologicsglobal cdmoendbiopharmaservices https://samsungbiologics.com/ir/stock-info/listing-information Listing Information | Samsung Biologics Find Samsung Biologics stock listing information(KS 207940) here to learn more about our financial performance. listing informationsamsung biologics https://samsungbiologics.com/media/science-technology?schBoardCtgryCcd=2 Resources | Samsung Biologics Newsroom Check out our latest scientific contents including the whitepaper, videos, and webinars at our Media Center. samsung biologicsresourcesnewsroom https://www.cityam.com/samsung-biologics-under-ceo-john-rim-faces-new-esg-risk-after-rejecting-ruling-in-contract-worker-discrimination-case/ Samsung Biologics Under CEO John Rim Faces New ESG Risk After Rejecting Ruling in Contract Worker... Apr 2, 2026 - After the Incheon Regional Labor Relations Commission ruled in Case No. Incheon 2025 Discrimination 10 that the exclusion of contract workers from holiday gift... samsung biologicsceo johnfaces newesg riskrim https://samsungbiologics.com/about/locations Location | Samsung Biologics Samsung Biologics is located at Songdo, South Korea, the heart of the Asian biopharmaceutical hub and it can be conveniently reached from all major... location samsungbiologics https://samsungbiologics.com/sustainability/bcms BCMS | Samsung Biologics Samsung Biologics strengthens trust with clients through its Business Continuity Management System, ensuring stable drug supply amid the pandemic. samsung biologicsbcms https://samsungbiologics.com/media/newsroom Newsroom | Samsung Biologics Check out our latest contents including company news, our story, and scientific contents at the Samsung Biologics Newsroom. samsung biologicsnewsroom https://samsungbiologics.com/media/company-news?schboardctgryccd=1 Company News | Samsung Biologics Newsroom Check out Samsung Biologics latest company news on our Newsroom to stay up to date with the ongoing events. Please use the resources on this page, or contact... company newssamsung biologicsnewsroom https://samsungbiologics.com/ir/stock-info/ownership-structure Ownership Structure | Samsung Biologics Click here to view and learn more about Samsung Biologics ownership structure of stock shares and its details. ownership structuresamsung biologics https://pulse.mk.co.kr/news/english/12006067 Samsung Biologics secures first manufacturing base in U.S. - 매일경제 영문뉴스 펄스(Pulse) samsung biologicssecures firstmanufacturing basepulse https://samsungbiologics.com/sustainability/esg-report ESG Resources | Samsung Biologics Samsung Biologics has issued the ESG report. esg resourcessamsung biologics https://samsungbiologics.com/sustainability/esg-policy ESG Policy | Samsung Biologics Samsung Biologics builds stakeholder trust through legal compliance and transparent management. esg policysamsung biologics https://samsungbiologics.com/sustainability/articles Articles of Incorporation | Samsung Biologics Samsung Biologics established its articles of incorporation under the Commercial Act and publishes an annual corporate governance report. samsung biologicsarticlesincorporation